Literature DB >> 11016457

Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy.

R Chibber1, B M Ben-Mahmud, D Coppini, E Christ, E M Kohner.   

Abstract

The exact mechanism for capillary occlusion in diabetic retinopathy is still unclear, but increased leukocyte-endothelial cell adhesion has been implicated. We examined the possibility that posttranslational modification of surface O-glycans by increased activity of core 2 transferase (UDP-Glc:Galbeta1-3GalNAcalphaRbeta-N-acetylglucoaminyltr ansferase) is responsible for increased adhesion of leukocytes to vascular endothelium in diabetes. The mean activity of core 2 transferase in polymorphonuclear leukocytes isolated from type 1 and type 2 diabetic patients was higher compared with age-matched control subjects (1,638 +/- 91 [n = 42] vs. 249 +/- 35 pmol x h(-1) x mg(-1) protein [n = 24], P = 0.00013; 1,459 +/- 194 [n = 58] vs. 334 +/- 86 [n = 11], P = 0.01). As a group, diabetic patients with retinopathy had significantly higher mean activity of core 2 transferase compared with individuals with no retinopathy. There was a significant association between enzyme activity and severity of retinopathy in type 1 and type 2 diabetic patients. There was a strong correlation between activity of core 2 transferase and extent of leukocyte adhesion to cultured retinal capillary endothelial cells for diabetic patients but not for age-matched control subjects. Results from transfection experiments using human myelocytic cell line (U937) demonstrated a direct relationship between increased activity of core 2 transferase and increased binding to cultured endothelial cells. There was no relationship between activity of core 2 transferase and HbA(1c) (P = 0.8314), serum advanced glycation end product levels (P = 0.4159), age of the patient (P = 0.7896), and duration of diabetes (P = 0.3307). On the basis that branched O-glycans formed by the action of core 2 transferase participate in leukocyte adhesion, the present data suggest the involvement of this enzyme in increased leukocyte-endothelial cell adhesion and the pathogenesis of capillary occlusion in diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016457     DOI: 10.2337/diabetes.49.10.1724

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  The pathogenesis of diabetic retinopathy.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy.

Authors:  B M Ben-Mahmud; W H Chan; R M Abdulahad; A Datti; A Orlacchio; E M Kohner; R Chibber
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

Review 3.  A review of therapies for diabetic macular oedema and rationale for combination therapy.

Authors:  W M K Amoaku; S Saker; E A Stewart
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

4.  Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier.

Authors:  Claire L Allen; Katarzyna Wolanska; Naseeb K Malhi; Andrew V Benest; Mark E Wood; Winfried Amoaku; Roberta Torregrossa; Matthew Whiteman; David O Bates; Jacqueline L Whatmore
Journal:  Front Cell Dev Biol       Date:  2021-09-07

Review 5.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

Review 6.  Pathophysiology of diabetic retinopathy.

Authors:  Joanna M Tarr; Kirti Kaul; Mohit Chopra; Eva M Kohner; Rakesh Chibber
Journal:  ISRN Ophthalmol       Date:  2013-01-15

Review 7.  Diabetic Retinopathy: Pathophysiology and Treatments.

Authors:  Wei Wang; Amy C Y Lo
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.